Genetic Variation of Alpha B Crystallin Cryab and CSF Alpha B Crystallin in Patients with Multiple Sclerosis (original) (raw)
B-Crystallin genotype has impact on the multiple sclerosis phenotype
Amado Salvador Peña
Neurology, 2003
View PDFchevron_right
CRYAB promoter polymorphisms: Influence on multiple sclerosis susceptibility and clinical presentation
Jette Frederiksen
Clinica Chimica Acta, 2007
View PDFchevron_right
Phosphorylation of α-crystallin B in Alexander's disease brain
Raul Chiesa
FEBS Letters, 1991
View PDFchevron_right
Multiple sclerosis genetics: Results from meta-analyses of candidate-gene association studies
kalthoum Tizaoui
Cytokine, 2018
View PDFchevron_right
Genome-Wide Multiple Sclerosis Association Data and Coagulation
Silvia Romano
Frontiers in Neurology, 2019
View PDFchevron_right
Chaperone Activity of α B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis
Jonathan Rothbard
Journal of Immunology, 2011
View PDFchevron_right
Response to Comment on “Chaperone Activity of α B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis”
Jonathan Rothbard
Journal of Immunology, 2011
View PDFchevron_right
MEFV gene mutations in patients with Multiple Sclerosis
Aysun Unal
Journal of the Neurological Sciences, 2010
View PDFchevron_right
Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial
Edna Venneker
PLOS ONE, 2015
View PDFchevron_right
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
Luisa Bernardinelli
Cell, 2018
View PDFchevron_right
Genetic associations with brain cortical thickness in multiple sclerosis
Eduardo Caverzasi
Genes, Brain and Behavior, 2015
View PDFchevron_right
EBV-Induced Expression and HLA-DR-Restricted Presentation by Human B Cells of αB-Crystallin, a Candidate Autoantigen in Multiple Sclerosis
Johannes van Noort
The Journal of Immunology, 1999
View PDFchevron_right
Chaperone Activity of B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis
Jonathan Rothbard, Michael Kurnellas
The Journal of Immunology, 2011
View PDFchevron_right
Response to Comment on "Chaperone Activity of B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis
Jonathan Rothbard
The Journal of Immunology, 2011
View PDFchevron_right
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Lars Andersson
Journal of Proteomics, 2010
View PDFchevron_right
Ile587Val Polymorphism of the eIF2B5 Gene as Susceptibility Factor for Multiple Sclerosis
William Sproviero
Neuroscience & Medicine, 2011
View PDFchevron_right
MYO9B polymorphisms in multiple sclerosis
Elisabeth Celius
European Journal of Human Genetics, 2009
View PDFchevron_right
Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin
Laura Lovato
Journal of Neuroimmunology, 2011
View PDFchevron_right
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Simon Broadley, Allan Kermode
Nature Genetics, 2009
View PDFchevron_right
Comment on "Chaperone Activity of B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis
Jeffrey Bajramovic
The Journal of Immunology, 2011
View PDFchevron_right
EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis
Marianne van Stipdonk
Journal of immunology (Baltimore, Md. : 1950), 1999
View PDFchevron_right
Confirmation of association between multiple sclerosis and CYP27B1
Lars Alfredsson
European Journal of Human Genetics, 2010
View PDFchevron_right
Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission
John Pollard
BMC Medical Genetics, 2008
View PDFchevron_right
Multiple Sclerosis Journal
Ayse Altintas
2013
View PDFchevron_right
Multiple sclerosis: following clues from cause to cure
Heather MacLean
The Lancet Neurology, 2009
View PDFchevron_right
Histocompatibility Determinants in Multiple Sclerosis
Casper Jersild
Immunological Reviews, 1975
View PDFchevron_right
Genetics of Amyotrophic Lateral Sclerosis
mehdi ghasemi
American Journal of Neuroradiology, 2014
View PDFchevron_right
Multiple sclerosis: Association of gelatinase B/matrix metalloproteinase-9 with risk and clinical course the disease
Sonia Batista
Multiple Sclerosis and Related Disorders, 2017
View PDFchevron_right
Plasma osteopontin levels in multiple sclerosis
Jordi Río
Journal of Neuroimmunology, 2005
View PDFchevron_right
A whole genome association study in Finnish multiple sclerosis patients with 3669 markers
Jorma Ilonen
Journal of Neuroimmunology, 2003
View PDFchevron_right
Analysis of viral and genetic factors in South African patients with multiple sclerosis
Nico De Villiers
Metabolic Brain Disease, 2006
View PDFchevron_right
Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis
Rosanna Asselta, Rachele Cagliani
Human Genetics, 2012
View PDFchevron_right
The R620W Polymorphism of the Protein Tyrosine Phosphatase PTPN22 Is Not Associated with Multiple Sclerosis
Ghazi Chabchoub
The American Journal of Human Genetics, 2005
View PDFchevron_right
Protective and Therapeutic Role for α B-Crystallin in Autoimmune Demyelination
Lawrence Steinman
Clinical Immunology, 2007
View PDFchevron_right
B-cell populations discriminate between pediatric- and adult-onset multiple sclerosis
Friedrich Ebinger
Neuroimmunology and Neuroinflammation, 2016
View PDFchevron_right